Japan generic drug maker Nichi-Iko to acquire Sagent of U.S.

Yuichi Tamura, president of generic drug company Nichi-Iko Pharmaceutical Co., has a press conference in Toyama, Japan, on July 11, 2016. Nichi-Iko will acquire U.S. generic drug maker Sagent Pharmaceuticals Inc. for roughly $736 million in a bid to expand its presence in the U.S. market. (Kyodo) ==Kyodo